EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity

Devika Tripathi iD, Prashant Pandey, Sakshi Sharma, Awani K Rai, Manjunatha Prabhu B H

BioImpacts · 02.11.2024

DOI: 10.34172/bi.30573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioImpacts, online erschienen am 02.11.2024. Verfasst von Devika Tripathi und 4 weiteren Autor:innen. Beteiligte Einrichtung: PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur Uttar Pradesh, 208002, India. Die Arbeit wurde bisher 44-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

By integrating the cutting-edge principles of nanotechnology with medical science, nanomedicine offers unprecedented opportunities to develop advanced drug delivery systems that surpass the limitations of conventional therapies. These nanoscale systems are designed to enhance treatments' efficacy, specificity, and safety by optimizing pharmacokinetics and biodistribution, ensuring that therapeutic agents reach their intended targets with minimal side effects. The article provides an in-depth analysis of nanomaterials' pivotal role in overcoming challenges related to drug delivery, including the ability to bypass biological barriers, improve bioavailability, and achieve controlled release of drugs. Despite these promising advancements, the transition of nanomedicine from research to clinical practice faces significant hurdles. The review highlights key obstacles such as patient heterogeneity, physiological variability, and the complex ADME (Absorption, Distribution, Metabolism, Excretion) profiles of nanocarriers, which complicate treatment predictability and effectiveness. Moreover, the article addresses the issues of limited tissue penetration, variable patient responses, and the need for standardized protocols in nanomaterial characterization, all of which hinder the widespread clinical adoption of nanomedicine. Nevertheless, the potential of nanomedicine in revolutionizing personalized cancer therapy remains immense. The article advocates for increased translational research and international collaboration to overcome these challenges, paving the way for fully realizing nanomedicine's capabilities in precision oncology and beyond.

Schlagwörter

Stichwörter der Autor:innen

ADMEAssessmentDrug therapyNanomedicinePrecision deliverySafety

Autor:innen und Institutionen

  • PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur Uttar Pradesh, 208002, India.
  • Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh 226025, India.
  • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
  • Department of Food Protection and Infestation Control, CSIR- Central Food Technological Research Institute (CFTRI), Mysore-570012, Karnataka, India.

ORCID-Profile: Devika Tripathi

Zitieren

APA

Tripathi, D., Pandey, P., Sharma, S., Rai, A. K., & Prabhu B H, M. (2024). Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity. BioImpacts. https://doi.org/10.34172/bi.30573

Vancouver

Tripathi D, Pandey P, Sharma S, Rai AK, Prabhu B H M. Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity. BioImpacts. 2024. doi:10.34172/bi.30573

BibTeX
@article{Tripathi2024,
  author = {Tripathi, Devika and Pandey, Prashant and Sharma, Sakshi and Rai, Awani K and Prabhu B H, Manjunatha},
  title = {Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity},
  journal = {BioImpacts},
  year = {2024},
  doi = {10.34172/bi.30573}
}
Kostenlos starten →